此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Supervised vs. Home Schroth Exercise in AIS

2026年8月31日 更新者:Mesut Arslan、Bitlis Eren University

Comparative Effectiveness of Supervised vs. Home-Based Schroth Exercises in Adolescent Idiopathic Scoliosis: A Randomized Controlled Trial

This study aims to compare the effectiveness of supervised Schroth exercises versus a home-based exercise program in adolescents with Adolescent Idiopathic Scoliosis (AIS).

研究概览

详细说明

Adolescent Idiopathic Scoliosis (AIS) is a three-dimensional spinal deformity that develops in children aged 10-18, affecting approximately 0.47% to 12% of this population. If left untreated, curves between 10° and 45° may progress, leading to pain, breathing difficulties, postural problems, and reduced quality of life. Although bracing and surgery are traditional options, they have limitations. Physiotherapeutic scoliosis-specific exercises (PSSE), particularly the Schroth method, are increasingly recommended as a first-line conservative treatment.

研究类型

介入性

注册 (估计的)

62

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人

接受健康志愿者

不

描述

Inclusion Criteria:

  • Diagnosis of Adolescent Idiopathic Scoliosis (idiopathic etiology)
  • Age between 10 and 18 years
  • Cobb angle between 10° and 45°
  • Able to participate in a 5-day/week exercise program (supervised or home-based)
  • Patient and parent/guardian provide written informed consent
  • Sufficient cooperation to comply with the study protocol and complete assessments

Exclusion Criteria:

  • Non-idiopathic scoliosis (neuromuscular, congenital, functional, etc.)
  • Prior or planned spinal surgery
  • Neurological, rheumatological, metabolic, or cardiopulmonary disease that would interfere with participation
  • Brace treatment within the last 6 months or planned during the study
  • Regular scoliosis-specific exercise (more than 2 days/week) within the last 6 months

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Supervised Schroth Exercise Group (SSEG)
Participants in this group will receive the exercise program under direct, one-on-one supervision by a physiotherapist. This is a purely physical exercise intervention. No drugs or devices are used as part of the intervention. Only the Schroth exercise program is administered.
60-minute Schroth exercise sessions, 5 days/week for 12 weeks, delivered under one-on-one physiotherapist supervision. Includes 3D auto-correction, rotational breathing, postural stabilization, and curve-specific exercises (shoulder counter-pull, muscle cylinder, side-lying, sailing, prominent hip, Schroth walking)
有源比较器:Home Exercise Program Group (HEPG)
Participants in this group will be provided with an individualized home exercise program that matches the supervised group in terms of principles, content, and duration. This is a purely physical exercise intervention. No drugs or devices are used as part of the intervention. Only the Schroth exercise program is administered.
Same 60-minute Schroth exercise program, 5 days/week for 12 weeks, performed at home without direct physiotherapist supervision. Participants receive initial instruction and an individualized exercise booklet.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Cobb Angle
大体时间:Baseline and 3 months post-intervention
Change in the primary curve Cobb angle measured on standing posteroanterior full-spine radiographs, assessed at baseline and 3 months post-intervention.
Baseline and 3 months post-intervention

次要结果测量

结果测量
措施说明
大体时间
Change in Trunk Rotation Angle (ATR)
大体时间:Baseline and 12 weeks
Change in angle of trunk rotation measured using a scoliometer during the Adam's Forward Bend Test.
Baseline and 12 weeks
Change in Thoracic Kyphosis
大体时间:Baseline and 12 weeks
Change in thoracic kyphosis angle measured using an inclinometer at T1-T2 and T12-L1 levels.
Baseline and 12 weeks
Change in Lumbar Lordosis
大体时间:Baseline and 12 weeks
Change in lumbar lordosis angle measured using an inclinometer at T12-L1 and S2-S3 levels.
Baseline and 12 weeks
Respiratory Function assessed by Spirometry (FVC, FEV1, FEV1/FVC, PEF, FEF25-75%)
大体时间:Baseline and 12 weeks
Respiratory function will be assessed using a spirometry device. The following parameters will be recorded and analyzed: Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), the FEV1/FVC ratio, Peak Expiratory Flow (PEF), and Forced Expiratory Flow at 25-75% of FVC (FEF25-75%).
Baseline and 12 weeks
Change in Pain Level
大体时间:Baseline and 12 weeks
Change in musculoskeletal pain/discomfort assessed using the Turkish-validated Cornell Musculoskeletal Discomfort Questionnaire (T-CMDQ) [19]. The questionnaire evaluates discomfort in 18 body regions over the past week across three dimensions: frequency, severity, and functional impact on daily activities. A risk score is calculated for each body region by multiplying these three parameters. For bilaterally assessed regions, the higher of the two side-specific scores is used in the analysis. Higher scores indicate worse outcomes.
Baseline and 12 weeks
Change in Quality of Life
大体时间:Baseline and 12 weeks
Change in health-related quality of life assessed using the Turkish-validated Scoliosis Research Society-22 (SRS-22) questionnaire. The questionnaire consists of five domains: function, pain, self-image, mental health, and treatment satisfaction. Each item is scored from 1 (worst) to 5 (best); domain and total scores range from 1 to 5. Higher scores indicate better outcomes. The treatment satisfaction domain will be assessed only at 12 weeks; other domains assessed at both baseline and 12 weeks.
Baseline and 12 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年8月31日

初级完成 (估计的)

2027年8月31日

研究完成 (估计的)

2027年8月31日

研究注册日期

首次提交

2026年8月15日

首先提交符合 QC 标准的

2026年8月20日

首次发布 (实际的)

2026年8月21日

研究记录更新

最后更新发布 (实际的)

2026年9月1日

上次提交的符合 QC 标准的更新

2026年8月31日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • E.9290

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅